Life Sciences

In a time of tighter drug prices, extreme competition, and empowered patients, one thing has become clear for biopharma organizations:...

Every year, too many people with health problems fall through the cracks of a complex care continuum. They go missing—poof—amounting...

Artificial intelligence (AI) has enormous potential in healthcare, but all too often, it gets misunderstood. Especially with the proliferation of...

While pharma is increasingly leveraging AI to derive data insights, enhance content development, and inform sales and marketing approaches, there...

In a span of years—months, really—artificial intelligence (AI) has matured mightily in the public’s eye. Once met with skepticism and...

Reflecting on Insights from the Reuters Pharma USA Conference In a panel discussion at the Reuters Pharma USA Conference, industry...

The 2024 J.P. Morgan Healthcare Conference provided a robust platform for leaders, innovators, and disruptors in the healthcare industry to...

Panelists share their perspectives on how ethically trained AI can combat bias within the healthcare system, leading to greater access...

Three core themes from MedTech 2022: Diversity and inclusion in clinical trials, digital transformation, and expanding care into the home....